Literature DB >> 1164588

Effects of desipramine on neuronal responses to dopamine, noradrenaline, 5-hydroxytryptamine and acetylcholine in the caudate nucleus of the rat.

P Bevan, C M Bradshaw, E Szabadi.   

Abstract

1 The sensitivity of single neurones to microelectrophoretically applied dopamine, noradrenaline (NA), 5-hydroxytryptamine (5-HT) and acetylcholing (ACh) was investigated in the caudate nucleus of the rat, anaesthetized with halothane. Both excitatory and depressant responses could be observed to each of the agonists. There was a high correlation between the direction of responses to dopamine and noradrenaline, whereas there was no significant correlation between the direction of responses to dopamine and ACh. 2 The effect of desipramine was studied on both excitatory and depressant responses to dopamine, NA and 5-HT, and on excitatory responses to ACh. Both potentiation and antagonism of neuronal responses to monoamines and ACh could be observed after a brief application of desipramine. 3 Excitatory responses to glutamate were not affected by desipramine. 4 The observation that responses to dopamine and NA can be potentiated by desipramine in the caudate nucleus suggests that uptake blockade is not a prerequisite for potentiation. 5 It is suggested that the potentiation of neuronal responses to dopamine by desipramine may be responsible for the therapeutic efficacy of desipramine in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1164588      PMCID: PMC1666469          DOI: 10.1111/j.1476-5381.1975.tb07567.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Tricyclic antidepressants and monoamines: the relationship between uptake blockade and potentiation of neuronal responses.

Authors:  P Bevan; C M Bradshaw; E Szabadi
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

2.  The pathogenesis of Parkinson's disease: a new hypothesis.

Authors:  A BARBEAU
Journal:  Can Med Assoc J       Date:  1962-10-13       Impact factor: 8.262

3.  Desipramine in treatment of Parkinson's disease. A placebo-controlled study.

Authors:  L Laitinen
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

4.  Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue.

Authors:  S B Ross; A L Renyi
Journal:  Eur J Pharmacol       Date:  1969-09       Impact factor: 4.432

5.  Lesion of substantia nigra: biochemical and behavioral effects in rats.

Authors:  W Gumulka; A Ramirez del Angel; R Samanin; L Valzelli
Journal:  Eur J Pharmacol       Date:  1970-04       Impact factor: 4.432

6.  Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis.

Authors:  F E Bloom; E Costa; G C Salmoiraghi
Journal:  J Pharmacol Exp Ther       Date:  1965-11       Impact factor: 4.030

7.  Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons.

Authors:  A S Horn; J T Coyle; S H Snyder
Journal:  Mol Pharmacol       Date:  1971-01       Impact factor: 4.436

8.  Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents.

Authors:  S B Ross; A L Renyi
Journal:  Eur J Pharmacol       Date:  1967-12       Impact factor: 4.432

9.  The reflection of ejecting and retaining currents in the time-course of neuronal responses to microelectrophoretically applied drugs.

Authors:  C M Bradshaw; E Szabadi; M H Roberts
Journal:  J Pharm Pharmacol       Date:  1973-07       Impact factor: 3.765

10.  Patterns of central neurons responses to suspected transmitters.

Authors:  G C Salmoiraghi; C N Stefanis
Journal:  Arch Ital Biol       Date:  1965-12-10       Impact factor: 1.000

View more
  6 in total

1.  Potentiation by desipramine of neuronal responses to mescaline.

Authors:  P Bevan; C M Bradshaw; E Szabadi
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

2.  The effect of some neuroleptics on the interaction of cortically and nigrally evoked potentials in the rat striatum.

Authors:  H R Olpe; W P Koella
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

3.  Rolipram, a stereospecific inhibitor of calmodulin-independent phosphodiesterase, causes beta-adrenoceptor subsensitivity in rat cerebral cortex.

Authors:  J E Schultz; B H Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

4.  Potentiation of responses to monoamines by antidepressants after destruction of monoamine afferents.

Authors:  R S Jones; M H Roberts
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

5.  Comparison of the responses of single cortical neurones to tyramine and noradrenaline: effects of desipramine.

Authors:  P Bevan; C M Bradshaw; R Y Pun; N T Slater; E Szabadi
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

6.  Tricyclic anti-depressant induced mania.

Authors:  B B Sethi; R Prakash; M Sharma; J Sahai
Journal:  Indian J Psychiatry       Date:  1980-10       Impact factor: 1.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.